SCHEMBL2276123

SCHEMBL2276123

N#CCc1ccc(Cl)c(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.45
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
CNR1 P21554 1/20 0.41
KIF11 P52732 1/20 0.40
AR P10275 1/20 0.40
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
IL2 P60568 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
PTGES O14684 2/20 0.38
MAOB P27338 1/20 0.37
GRM2 Q14416 1/20 0.37
IDO1 P14902 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2267261 0.79 KIF11 (0.57) KIF11MAOBIDO1NAAARXRA
SCHEMBL246959 0.77 TAAR1 (0.48) KIF11MAOBIDO1NAAA
SCHEMBL2276117 0.77 AR (0.46) ARCTSKIDO1
SCHEMBL28087912 0.75 IL2 (0.50) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL1678953 0.74 IDO1 (0.56) ARCTSSCTSKIDO1RXRA
SCHEMBL10568208 0.72 SRD5A2 (0.46) KIF11MAOBIDO1NAAA
SCHEMBL7594667 0.71 RXRA (0.54) KIF11MAOBNAAARXRARXRB
SCHEMBL21767817 0.71 DAO (0.44) KIF11ARIDO1RXRARXRB
SCHEMBL29941066 0.71 DAO (0.44) KIF11ARIDO1RXRARXRB
SCHEMBL30858772 0.71 SLC6A4 (0.43) CTSSCTSKIDO1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1714961-B1 INDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2015-12-09 EP disclosed
US-7994196-B2 Indazole compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-08-09 US disclosed
US-20070173537-A1 Indazole compound and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2007-07-26 US disclosed
EP-1714961-A1 INDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2006-10-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173537-A1 Indazole compound and pharmaceutical use thereof CYP3A5, CYP3A43, TP53 CASR 4519/4885PSEN1 4459/4885PSEN2 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.